Fact based stock research
ChemoMetec (CPSE:CHEMM)

DK0060055861

ChemoMetec stock research in summary

chemometec.com


ChemoMetec shares have a market-typical stock price level. While they show above average growth, they are riskily financed, and are poor value. We recommend evaluating whether the future of the company ChemoMetec is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.


Latest Obermatt Ranks


Country Denmark
Industry Life Sciences Tools & Services
Index
Size class X-Small

October 7, 2021. Stock data may be delayed. Login to get the most recent research.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for ChemoMetec from October 7, 2021.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.